Professor Elio Riboli is Chair in Cancer Epidemiology and Prevention and was formerly the Director of the School of Public Health at Imperial College London, rated one of the top two epidemiology and public health submissions to the UK’s Research Assessment Exercise (RAE) in 2009. He holds an M.D. degree (1977, State University of Milan), a Master of Public Health (1980, Milan) and a Master of Science in Epidemiology (1982, Harvard University). Professor Riboli is a Registered Physician (General Medical Council, UK, 2005) and an Honorary Fellow of the Royal College of Physicians (2008).
From 1983 to 2005 Professor Riboli was based at Lyon’s the International Agency for Research on Cancer (IARC), where he developed new research projects in the areas of nutrition, nutritional status and cancer. In 1989 he initiated the European Prospective Investigation into Cancer and Nutrition (EPIC), which sampled data from 500,000 subjects across 26 centres in ten countries. He was Head of the Nutrition and Hormones Group of IARC from 2004 to 2005.
Professor Riboli has co-authored over 310 peer-reviewed publications and over 100 book chapters and books and serves on editorial boards of major journals on nutrition, cancer and epidemiology.
In 2005 he joined Imperial College London as Professor of Cancer Epidemiology; in 2006 he was appointed Divisional Head of Epidemiology, Public Health and Primary Care, which later become the School of Public Health. Professor Riboli stepped down as Head of the School at the end of 2017.
et al., 2019, Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study., J Clin Endocrinol Metab, Vol:104, Pages:1293-1303
Riboli E, Predicting circulating CA125 levels among healthy premenopausal women, Cancer Epidemiology, Biomarkers and Prevention, ISSN:1055-9965
et al., 2019, General and abdominal adiposity and the risk of Parkinson's disease: A prospective cohort study., Parkinsonism Relat Disord
et al., 2019, Dairy Product Intake and Risk of Type 2 Diabetes in EPIC-InterAct: A Mendelian Randomization Study., Diabetes Care
et al., 2019, Meeting Report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer., Ann Oncol